| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated partial breast irradiation using MammoSite brachytherapy: a multidisciplinary approach to breast-conservation therapy
|
Tucker, Steven J.
|
|
2005
|
|
6 |
p. 477-482
6 p.
|
artikel
|
| 2 |
Acute monocytic leukemia presenting as pulmonary infiltration
|
Vlad, Oana
|
|
2008
|
|
6 |
p. 328-330
3 p.
|
artikel
|
| 3 |
Add your voice to the community dialogue
|
Henry, David H.
|
|
2006
|
|
6 |
p. 325-326
2 p.
|
artikel
|
| 4 |
AIDS-related cancers, Part I: Kaposi's sarcoma and cervical cancer
|
Bower, Mark
|
|
2005
|
|
6 |
p. 507-511
5 p.
|
artikel
|
| 5 |
An instructive case, a difference of opinion
|
Schwartzberg, Lee S.
|
|
2007
|
|
6 |
p. 399-400
2 p.
|
artikel
|
| 6 |
Are drug rebates good for oncology?
|
Klepper, Brian R.
|
|
2007
|
|
6 |
p. 367-
1 p.
|
artikel
|
| 7 |
Ask your lawyer
|
Doty, Lee W.
|
|
2006
|
|
6 |
p. 375-376
2 p.
|
artikel
|
| 8 |
Bilateral primary endodermal sinus tumor of the lung in a woman
|
Mishra, Sneha
|
|
2010
|
|
6 |
p. 283-285
3 p.
|
artikel
|
| 9 |
Biosimilars and targeted therapies pave the way ahead
|
Abraham, Jame
|
|
2012
|
|
6 |
p. 175-
1 p.
|
artikel
|
| 10 |
Biosimilars and their use in hematology and oncology
|
Waller, Cornelius F.
|
|
2012
|
|
6 |
p. 198-205
8 p.
|
artikel
|
| 11 |
Body counts and biostatistics: the chi-square test
|
Norman, Geofrey R.
|
|
2010
|
|
6 |
p. 286-287
2 p.
|
artikel
|
| 12 |
Cancer bills offer promise, gain momentum
|
|
|
2007
|
|
6 |
p. 420-
1 p.
|
artikel
|
| 13 |
Cancer costs: searching for savings
|
Young, Patrick
|
|
2010
|
|
6 |
p. 288-
1 p.
|
artikel
|
| 14 |
Cancer information on the Internet: the impact of employing specific search engines and search strategies
|
Markman, Timothy M.
|
|
2005
|
|
6 |
p. 502-504
3 p.
|
artikel
|
| 15 |
Cancer recurrence and survival in patients with early-stage triple-negative breast cancer
|
Christiansen, Neal P.
|
|
2012
|
|
6 |
p. 182-187
6 p.
|
artikel
|
| 16 |
Caveats…and solutions
|
Henry, David H.
|
|
2008
|
|
6 |
p. 283-
1 p.
|
artikel
|
| 17 |
Challenges of ensuring adherence to oral therapy in patients with solid malignancies
|
Staddon, Arthur P.
|
|
2011
|
|
6 |
p. 254-262
9 p.
|
artikel
|
| 18 |
Collaboration and exchange are key in facing new challenges
|
Schwartzberg, Lee S.
|
|
2011
|
|
6 |
p. 248-249
2 p.
|
artikel
|
| 19 |
Community Cancer Care Preservation Act introduced in Congress
|
Okon, Ted
|
|
2005
|
|
6 |
p. 536-537
2 p.
|
artikel
|
| 20 |
Community participation in NCI-sponsored clinical trials
|
Minasian, Lori
|
|
2006
|
|
6 |
p. 393-395
3 p.
|
artikel
|
| 21 |
Comparing aromatase inhibitors and tamoxifen as neoadjuvant therapy for breast cancer
|
Rana, Fauzia
|
|
2008
|
|
6 |
p. 301-305
5 p.
|
artikel
|
| 22 |
Debunking the myths of reimbursement, rebates, and oncologists' motives
|
Coplon, Steven M.
|
|
2007
|
|
6 |
p. 419-
1 p.
|
artikel
|
| 23 |
Denosumab: a new alternative for metastases
|
Abraham, Jame
|
|
2008
|
|
6 |
p. 291-293
3 p.
|
artikel
|
| 24 |
Denosumab: are we making progress in treating cancer-related bone metastasis?
|
Sehbai, Aasim
|
|
2008
|
|
6 |
p. 293-294
2 p.
|
artikel
|
| 25 |
Developing and operating multidisciplinary disease-specific clinics
|
Grusenmeyer, Patrick A.
|
|
2006
|
|
6 |
p. 385-387
3 p.
|
artikel
|
| 26 |
Direct-to-consumer genetic testing: helpful, harmful, or pure entertainment?
|
Pirzadeh-Miller, Sara
|
|
2011
|
|
6 |
p. 263-268
6 p.
|
artikel
|
| 27 |
Dose-independent synergistic response with gemcitabine and cisplatin in anthracycline-resistant breast cancer and reversal of resistance to gemcitabine with addition of paclitaxel
|
Gupta, Renuka
|
|
2007
|
|
6 |
p. 398-399
2 p.
|
artikel
|
| 28 |
Early treatment with rhIL-11 in heavily pretreated patients with gynecologic cancer
|
Pugmire, Douglas E.
|
|
2006
|
|
6 |
p. 357-362
6 p.
|
artikel
|
| 29 |
ESAs: whatever happened to evidence-based medicine?
|
Henry, David H.
|
|
2007
|
|
6 |
p. 389-390
2 p.
|
artikel
|
| 30 |
Extended-dosing epoetin alfa for chemotherapy-induced anemia: focus on elderly breast and colorectal cancer patients
|
Henry, David H.
|
|
2008
|
|
6 |
p. 310-321
12 p.
|
artikel
|
| 31 |
Fighting a lethal enemy
|
Henry, David H.
|
|
2008
|
|
6 |
p. 297-298
2 p.
|
artikel
|
| 32 |
Gadolinium—associated nephrogenic systemic fibrosis
|
McKoy, June M.
|
|
2008
|
|
6 |
p. 325-326
2 p.
|
artikel
|
| 33 |
Genetic testing and the need for more data
|
Pollock, Jondavid
|
|
2006
|
|
6 |
p. 333-334
2 p.
|
artikel
|
| 34 |
Genetic testing and the need for more data
|
Fowler, Eric
|
|
2006
|
|
6 |
p. 334-
1 p.
|
artikel
|
| 35 |
Hazardous drugs in oncology: the impact on practices of USP <797> and the NIOSH Alert
|
Power, Luci A.
|
|
2008
|
|
6 |
p. 343-346
4 p.
|
artikel
|
| 36 |
His own best advocate
|
Goldsmith, Myron
|
|
2005
|
|
6 |
p. 484-
1 p.
|
artikel
|
| 37 |
How one payer has stimulated a change in ESA therapy
|
Newcomer, Lee
|
|
2007
|
|
6 |
p. 393-
1 p.
|
artikel
|
| 38 |
How ‘tech toys’ have helped one doctor run a more efficient practice
|
Fried, John J.
|
|
2007
|
|
6 |
p. 417-
1 p.
|
artikel
|
| 39 |
HPV testing in cervical cancer screening: a pathologist's perspective
|
Flanagan, Melina
|
|
2009
|
|
6 |
p. 253-254
2 p.
|
artikel
|
| 40 |
If insurers jump the gun on policy, patients and practices suffer
|
Holcombe, Dawn G.
|
|
2007
|
|
6 |
p. 394-
1 p.
|
artikel
|
| 41 |
Impact of NCD guidelines on Medicare patients with chemotherapy-induced anemia receiving erythropoiesis-stimulating agents: results from a community oncology practice
|
Feinberg, Bruce
|
|
2009
|
|
6 |
p. 257-261
5 p.
|
artikel
|
| 42 |
Implementing a multisymptom chemotherapy risk assessment tool in two community oncology practices
|
Hwa, Charlotte
|
|
2007
|
|
6 |
p. 404-409
6 p.
|
artikel
|
| 43 |
Inside this issue: (Trying to) lobby for a healthcare bill
|
Henry, David H.
|
|
2009
|
|
6 |
p. 240-
1 p.
|
artikel
|
| 44 |
Integrating data for the next innovation Part 2
|
Schwartzberg, Lee S.
|
|
2010
|
|
6 |
p. 263-265
3 p.
|
artikel
|
| 45 |
Intraperitoneal chemotherapy as primary treatment of advanced ovarian cancer
|
Markman, Maurie
|
|
2006
|
|
6 |
p. 352-353
2 p.
|
artikel
|
| 46 |
Intraperitoneal therapy for stage III optimally debulked ovarian cancer
|
Tucker, Steven J.
|
|
2006
|
|
6 |
p. 348-349
2 p.
|
artikel
|
| 47 |
Intravenous chemotherapy with carboplatin/paclitaxel is the standard of care for patients with optimally resected stage III ovarian cancer
|
Ozols, Robert F.
|
|
2006
|
|
6 |
p. 350-351
2 p.
|
artikel
|
| 48 |
IV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agents
|
Anthony, Lowell B.
|
|
2011
|
|
6 |
p. 270-278
9 p.
|
artikel
|
| 49 |
Kansas City Cancer Center
|
Hennessy, John E.
|
|
2008
|
|
6 |
p. 348-349
2 p.
|
artikel
|
| 50 |
Low rate of neutropenia and related events in patients with breast cancer receiving pegfilgrastim from the first cycle of chemotherapy in community practices
|
Rader, Michael
|
|
2010
|
|
6 |
p. 273-280
8 p.
|
artikel
|
| 51 |
Management of chronic lymphocytic leukemia: an update
|
Kaufman, Matthew
|
|
2009
|
|
6 |
p. 271-278
8 p.
|
artikel
|
| 52 |
Management of rectal cancer: part II
|
Moore, Jill
|
|
2009
|
|
6 |
p. 265-270
6 p.
|
artikel
|
| 53 |
Managing cutaneous side effects of epidermal growth factor receptor (HER1/EGFR) inhibitors
|
Dick, Sarah E.
|
|
2005
|
|
6 |
p. 492-496
5 p.
|
artikel
|
| 54 |
Managing medical complications in patients with brain tumors
|
Rosenfeld, Myrna R.
|
|
2007
|
|
6 |
p. 411-416
6 p.
|
artikel
|
| 55 |
Marketing your practice
|
Helwick, Caroline
|
|
2009
|
|
6 |
p. 262-263
2 p.
|
artikel
|
| 56 |
Maximizing your profits with pharmacy control strategies
|
Phelan, Bob
|
|
2005
|
|
6 |
p. 498-500
3 p.
|
artikel
|
| 57 |
Medicare ACO cost incentives for potential prescribing shifts in cancer therapies worry stakeholders
|
Kelly, Cathy
|
|
2011
|
|
6 |
p. 287-288
2 p.
|
artikel
|
| 58 |
Medullary thyroid cancer: advances in treatment and management of common adverse events associated with therapy
|
Haddad, Robert I.
|
|
2012
|
|
6 |
p. 188-197
10 p.
|
artikel
|
| 59 |
Minimizing vincristine misadministration
|
Pangilinan, Joanna Maudlin
|
|
2007
|
|
6 |
p. 379-
1 p.
|
artikel
|
| 60 |
Neurolymphomatosis: the challenge of diagnosis and treatment
|
Muslimani, Alaa A.
|
|
2008
|
|
6 |
p. 339-341
3 p.
|
artikel
|
| 61 |
OVA1 test for preoperative assessment of ovarian cancer
|
Abraham, Jame
|
|
2010
|
|
6 |
p. 249-250
2 p.
|
artikel
|
| 62 |
Pharmaceutical patient assistance programs in the outpatient pharmacy of a large tertiary cancer center
|
Felder, Tisha M.
|
|
2011
|
|
6 |
p. 279-286
8 p.
|
artikel
|
| 63 |
P less than 0.05: statistical inference
|
Norman, Geoffrey R.
|
|
2009
|
|
6 |
p. 284-286
3 p.
|
artikel
|
| 64 |
Primary adenocarcinoma of the sigmoid colon diagnosed by uterine curettage: a case report
|
English, Cynthia Ann
|
|
2007
|
|
6 |
p. 402-403
2 p.
|
artikel
|
| 65 |
Prophylactic mastectomy and the clinical management of high-risk breast cancer patients
|
Calhoun, Kristine E.
|
|
2006
|
|
6 |
p. 379-382
4 p.
|
artikel
|
| 66 |
Protecting your patients' e-privacy—and yourself as well
|
Fried, John J.
|
|
2006
|
|
6 |
p. 390-391
2 p.
|
artikel
|
| 67 |
Rational combinations in metastatic breast cancer: bevacizumab with chemotherapy
|
Glück, Stefan
|
|
2010
|
|
6 |
p. 253-262
10 p.
|
artikel
|
| 68 |
Reaching the Latino community
|
Finkelstein, Joel B.
|
|
2006
|
|
6 |
p. 343-345
3 p.
|
artikel
|
| 69 |
Rebates are not the whole story
|
Bosserman, Linda D.
|
|
2007
|
|
6 |
p. 369-370
2 p.
|
artikel
|
| 70 |
Recognizing depression in cancer outpatients
|
Adkins, Barbara
|
|
2005
|
|
6 |
p. 528-533
6 p.
|
artikel
|
| 71 |
Reflecting back, looking forward
|
Vanchieri, Cori
|
|
2005
|
|
6 |
p. 469-471
3 p.
|
artikel
|
| 72 |
Regulating insurance: who wins and who loses?
|
Finkelstein, Joel B.
|
|
2006
|
|
6 |
p. 397-398
2 p.
|
artikel
|
| 73 |
Replacing CA-125 with OVA1 correctly identifies over 70% of malignancies missed by ACOG criteria
|
Ueland, Frederick R.
|
|
2010
|
|
6 |
p. 250-251
2 p.
|
artikel
|
| 74 |
Riding the Capitol Hill roller coaster
|
Henry, David H.
|
|
2007
|
|
6 |
p. 358-
1 p.
|
artikel
|
| 75 |
Risk-based strategy for vaccination of the 19-26-year-old female population
|
Makhija, Sharmila
|
|
2009
|
|
6 |
p. 251-252
2 p.
|
artikel
|
| 76 |
Ruxolitinib: juggling cancer biology and survival outcomes in myelofibrosis
|
Sharma, Manish
|
|
2012
|
|
6 |
p. 176-177
2 p.
|
artikel
|
| 77 |
Ruxolitinib treatment for myelofibrosis
|
Abraham, Jame
|
|
2012
|
|
6 |
p. 178-181
4 p.
|
artikel
|
| 78 |
Single cutaneous nodule as the first sign of lung cancer: a rare presentation
|
Agrawal, Prachi P.
|
|
2006
|
|
6 |
p. 367-368
2 p.
|
artikel
|
| 79 |
Small cell carcinoma of the lung with paraneoplastic features
|
Momah, Tobe
|
|
2009
|
|
6 |
p. 255-256
2 p.
|
artikel
|
| 80 |
The best of ASCO and beyond
|
Henry, David H.
|
|
2010
|
|
6 |
p. 247-
1 p.
|
artikel
|
| 81 |
The effects of ciprofloxacin and paclitaxel on metastatic and recurrent chondrosarcoma
|
Fox, Edward J.
|
|
2005
|
|
6 |
p. 516-522
7 p.
|
artikel
|
| 82 |
The FDA spoke: now what?
|
Boccia, Ralph V.
|
|
2007
|
|
6 |
p. 392-393
2 p.
|
artikel
|
| 83 |
The new genetic privacy law
|
Leib, Jennifer R.
|
|
2008
|
|
6 |
p. 351-354
4 p.
|
artikel
|
| 84 |
The Patient Protection and Affordable Care Act: no rhetoric, just the facts
|
Arkoosh, Valerie A.
|
|
2012
|
|
6 |
p. 206-209
4 p.
|
artikel
|
| 85 |
The run-up to the ESA controversy and where we go from here
|
Gleason, Kara J.
|
|
2007
|
|
6 |
p. 390-392
3 p.
|
artikel
|
| 86 |
Treating chemotherapy-induced anemia following the revised labeling for ESAs
|
Shord, Stacy S.
|
|
2009
|
|
6 |
p. 279-282
4 p.
|
artikel
|
| 87 |
Treatment considerations for today's elderly
|
Nelson, Marybeth
|
|
2007
|
|
6 |
p. 379-
1 p.
|
artikel
|
| 88 |
Treatment options for cutaneous T-cell lymphoma expand
|
Rhee, Jay
|
|
2007
|
|
6 |
p. 386-
1 p.
|
artikel
|
| 89 |
Turning back the tide
|
Schwartzberg, Lee S.
|
|
2005
|
|
6 |
p. 465-
1 p.
|
artikel
|
| 90 |
Update on HPV vaccination and HPV screening
|
Abraham, Jame
|
|
2009
|
|
6 |
p. 249-251
3 p.
|
artikel
|
| 91 |
Vorinostat in cutaneous T-cell lymphoma
|
Abraham, Jame
|
|
2007
|
|
6 |
p. 384-385
2 p.
|
artikel
|
| 92 |
Vorinostat: pharmacoeconomic issues
|
Cumpston, Aaron
|
|
2007
|
|
6 |
p. 386-
1 p.
|
artikel
|
| 93 |
Where faith and medicine meet
|
Weir III, Alva B.
|
|
2006
|
|
6 |
p. 372-374
3 p.
|
artikel
|
| 94 |
Why not test the tumor first?
|
Pawelski, Gregory D.
|
|
2006
|
|
6 |
p. 333-
1 p.
|
artikel
|
| 95 |
Why not test the tumor first?
|
Robinson, William
|
|
2006
|
|
6 |
p. 333-
1 p.
|
artikel
|
| 96 |
You've got mail
|
Cavallo, Jo
|
|
2006
|
|
6 |
p. 389-390
2 p.
|
artikel
|
Tijdschrift beschrijving